VivoSeq
Other

Microcirculation

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Microcirculation is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

6/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

31

clinical trials

Completed14 · 45%
Unknown status12 · 39%
Recruiting3 · 10%
Terminated1 · 3%
Withdrawn1 · 3%

Trial Activity

31 trials

Maternal Microcirculation & SDF Imaging
Completed·IIWK Health Centre·Phase 4·NCT02376192·32 enrolled
Microcirculation & ASICs
Completed·HHospices Civils de Lyon·N/A·NCT01246180·20 enrolled
Comparing Ticagrelor Versus Clopidogrel on Microcirculation
Completed··N/A·NCT02618733·120 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)